Alejandro Arbona-Lampaya

Mr. Alejandro Arbona-Lampaya


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2025 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
AAAlejandro Arbona-Lampaya
Alejandro Arbona-Lampaya
RPRicardo A Pérez-Ojeda
Ricardo A Pérez-Ojeda
MSMelanie Santos-Marrero
Melanie Santos-Marrero
APAdrián Pérez-Aybar
Adrián Pérez-Aybar

14 July 2025 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
AAAlejandro Arbona-Lampaya
Alejandro Arbona-Lampaya
AOAlejandro Odeh-Couvertier
Alejandro Odeh-Couvertier
RJRicardo Sánchez Jiménez
Ricardo Sánchez Jiménez
EÁEduardo Labat Álvarez
Eduardo Labat Álvarez
Traumatic brain injury (TBI) is a significant cause of neurological morbidity, often leading to blood–brain barrier (BBB) dysfunction and secondary injury mechanisms. Recent advancements in neuroimaging have highlighted traumatic meningeal enhancement (TME) on contrast-enhanced fluid-attenuated inversion recovery (FLAIR) MRI as a promising biomarker for detecting BBB disruption following TBI. TME, which is hypothesized to arise from vascular injury and inflammatory cascades that compromise the blood-meningeal barrier, has been associated with both acute trauma and long-term neurovascular dysfunction. Its presence, particularly when linked to subdural hematomas and delayed contrast extravasation, not only reflects the immediate severity of the injury but may also indicate chronic neuroinflammatory processes and persistent cognitive deficits. In this review, we gather current evidence on the pathophysiology of TME including its associations with vascular permeability, subdural hematoma, and prolonged inflammatory responses. We explore its potential as a biomarker for injury severity and prognosis in TBI patients. Finally, we further discuss the critical need for standardized imaging protocols and longitudinal studies to determine the clinical implications of persistent TME.

10 December 2024 in Journal of Affective Disorders
Verified
Journal Article
Open access
AAAlejandro Arbona-Lampaya
Alejandro Arbona-Lampaya
HSHeejong Sung
Heejong Sung
ADAlexander D'AMico
Alexander D'AMico
EKEmma E.M. Knowles
Emma E.M. Knowles
EBEmily K. Besançon
Emily K. Besançon
FMFrancis J. McMahon
Francis J. McMahon
Bipolar disorder (BD) presents with a wide range of symptoms that vary among relatives, casting doubt on categorical illness models. To address this uncertainty, we investigated the heritability and genetic relationships between categorical and dimensional models of BD in a family sample. This retrospective study included participants (n = 397 Females, n = 329 Males, mean age 47 yr) in the Amish-Mennonite Bipolar Genetics (AMBiGen) study from North and South America that were assigned categorical mood disorder diagnoses ("narrow" or "broad") by structured psychiatric interview and completed the Mood Disorder Questionnaire (MDQ), which assesses lifetime history of manic symptoms and associated impairment. MDQ-dimensions were analyzed by Principal Component Analysis (PCA). Heritability and genetic overlaps between categorical diagnoses and MDQ-dimensions were estimated with SOLAR-ECLIPSE within 432 genotyped participants. Individuals diagnosed with BD (n = 124) endorsed more MDQ items (61 %) than those with other mood disorders (26 %) or with no mood disorder (9 %), as expected. PCA suggested a three-component model for the MDQ, capturing 60 % of the variance. Heritability of the MDQ and its principal components was significant but modest (20-30 %, p < 0.001). Genetic correlations between MDQ measures and categorical diagnoses (ρG = 0.62-1.0; p < 0.001) were stronger than phenotypic correlations (ρP = 0.11-0.58; p < 0.001). Recruitment through probands with BD resulted in increased prevalence of BD in this sample, limiting generalizability. Unavailable genetic data reduced sample size for some analyses. Findings support a genetic continuity between dimensional and categorical models of BD and suggest that the MDQ is a useful phenotype measure for genetic studies of BD.

27 June 2023 in medRxiv
Verified
Preprint
Open access
PDF file
AAAlejandro Arbona-Lampaya
Alejandro Arbona-Lampaya
HSHeejong Sung
Heejong Sung
ADAlexander D’amico
Alexander D’amico
EKEmma E. M. Knowles
Emma E. M. Knowles
EBEmily K. Besançon
Emily K. Besançon
FMFrancis J. McMahon
Francis J. McMahon
Background: Bipolar disorder (BD) presents with a wide range of symptoms that vary among relatives, casting doubt on categorical illness models. To address this uncertainly, we investigated the heritability and genetic relationships between categorical and dimensional models of BD in a family sample. Methods: Participants in the Amish-Mennonite Bipolar Genetics (AMBiGen) study were assigned categorical mood disorder diagnoses by structured psychiatric interview and completed the Mood Disorder Questionnaire (MDQ), which assesses lifetime history of manic symptoms and associated impairment. Major MDQ dimensions were analyzed by Principal Component Analysis (PCA) in 726 participants. Heritability and genetic overlaps between categorical diagnoses and MDQ-derived dimensions were estimated with SOLAR-ECLIPSE within 432 genotyped participants. Results: MDQ scores were significantly higher among individuals diagnosed with BD and related disorders, as expected, but varied widely among relatives. PCA suggested a three-component model for the MDQ. Heritability of the MDQ score was 30% (p<0.001), evenly distributed across its three principal components. Strong and significant genetic correlations were found between categorical diagnoses and most MDQ measures. Limitations: Recruitment through probands with BD resulted in increased prevalence of BD in this sample, limiting generalizability. Unavailable genetic data reduced sample size for some analyses. Conclusion: Significant heritability and high genetic correlations between categorical diagnoses and MDQ measures support a genetic continuity between dimensional and categorical models of BD.

10 April 2023 in Biological Psychiatry
Verified
Journal Article
Closed access
ADAlexander D'Amico
Alexander D'Amico
HSHeejong Sung
Heejong Sung
EBEmily Besançon
Emily Besançon
AAAlejandro Arbona-Lampaya
Alejandro Arbona-Lampaya
AFAlly Freifeld
Ally Freifeld
FMFrancis J. McMahon
Francis J. McMahon

26 July 2025 in Journal of Ultrasound
Verified
Journal Article
Closed access
PDF file
AAAlejandro Arbona-Lampaya
Alejandro Arbona-Lampaya
KCKumarasen Cooper
Kumarasen Cooper
JBJenny T. Bencardino
Jenny T. Bencardino